Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 19:20
Neurocrine Biosciences Total Assets (Quarterly) : 5.359B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.359B |
| March 31, 2026 | 4.906B |
| December 31, 2025 | 4.753B |
| September 30, 2025 | 4.266B |
| June 30, 2025 | 3.890B |
| March 31, 2025 | 3.688B |
| December 31, 2024 | 3.847B |
| September 30, 2024 | 3.535B |
| June 30, 2024 | 3.305B |
| March 31, 2024 | 3.472B |
| December 31, 2023 | 3.33B |
| September 30, 2023 | 2.848B |
| June 30, 2023 | 2.613B |
| March 31, 2023 | 2.360B |
| December 31, 2022 | 2.402B |
| September 30, 2022 | 2.143B |
| June 30, 2022 | 2.006B |
| March 31, 2022 | 2.144B |
| December 31, 2021 | 2.072B |
| September 30, 2021 | 2.017B |
| June 30, 2021 | 1.956B |
| March 31, 2021 | 1.846B |
| December 31, 2020 | 1.735B |
| September 30, 2020 | 1.503B |
| June 30, 2020 | 1.516B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.362B |
| December 31, 2019 | 1.306B |
| September 30, 2019 | 1.180B |
| June 30, 2019 | 1.067B |
| March 31, 2019 | 957.72M |
| December 31, 2018 | 993.15M |
| September 30, 2018 | 933.75M |
| June 30, 2018 | 841.32M |
| March 31, 2018 | 806.36M |
| December 31, 2017 | 817.59M |
| September 30, 2017 | 772.50M |
| June 30, 2017 | 754.09M |
| March 31, 2017 | 289.36M |
| December 31, 2016 | 365.09M |
| September 30, 2016 | 399.16M |
| June 30, 2016 | 429.84M |
| March 31, 2016 | 459.33M |
| December 31, 2015 | 474.78M |
| September 30, 2015 | 492.44M |
| June 30, 2015 | 511.20M |
| March 31, 2015 | 527.78M |
| December 31, 2014 | 243.03M |
| September 30, 2014 | 257.75M |
| June 30, 2014 | 269.54M |
| March 31, 2014 | 279.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp. Plc | 624.36M |
| Liquidia Corp. | 521.92M |
| Incyte Corp. | 7.873B |
| Krystal Biotech, Inc. | 1.501B |
| Halozyme Therapeutics, Inc. | 2.577B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.666B |
| Shareholders Equity (Quarterly) | 3.694B |
| Debt to Equity Ratio | 0.1088 |
| Current Ratio | 1.872 |
| Net Debt Paydown Yield | 0.11% |